NCT07274813 2026-03-03
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase EARLY_PHASE1 Recruiting
Clinical Trials
29 trialsNCT05645523 2026-02-25
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
St. Jude Children's Research Hospital
Phase EARLY_PHASE1 Recruiting
NCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07412665 2026-02-17
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
Beijing Geekgene Technology Co., LTD
Phase EARLY_PHASE1 Not yet recruiting
NCT07220447 2026-02-12
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
City of Hope Medical Center
Phase EARLY_PHASE1 Recruiting
NCT06824155 2026-02-11
RAD202
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT07327632 2026-02-04
This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors
Innovent Biologics Technology Limited (Shanghai R&D Center)
Phase EARLY_PHASE1 Recruiting
NCT04733027 2026-01-22
Clever Peptide
Institut Curie
Phase EARLY_PHASE1 Active not recruiting
NCT07349160 2026-01-16
Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT05245682 2026-01-08
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Emory University
Phase EARLY_PHASE1 Active not recruiting
NCT07325123 2026-01-08
Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors
The First Affiliated Hospital of Xinxiang Medical College
Phase EARLY_PHASE1 Not yet recruiting
NCT05868486 2026-01-02
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
City of Hope Medical Center
Phase EARLY_PHASE1 Active not recruiting
NCT06380309 2025-12-23
A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE
Peking University
Phase EARLY_PHASE1 Recruiting
NCT06488950 2025-12-16
A Study of TIL in Advanced Solid Tumors (DFGD)
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1 Recruiting
NCT04967833 2025-12-11
A Study of GC101 TIL in Advanced Solid Tumors (TR)
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1 Recruiting
NCT07266311 2025-12-05
CAR-T for Claudin18.2 Positive Solid Tumors
Chengdu Ucello Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT05021120 2025-12-04
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours
Akeso
Phase EARLY_PHASE1 Completed
NCT07009184 2025-11-18
CleavHER
Radboud University Medical Center
Phase EARLY_PHASE1 Recruiting
NCT07182435 2025-09-19
Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Phase EARLY_PHASE1 Not yet recruiting
NCT05245058 2025-08-17
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd
Phase EARLY_PHASE1 Recruiting
NCT06822998 2025-08-17
HF50
HighField Biopharmaceuticals Corporation
Phase EARLY_PHASE1 Recruiting
NCT06610227 2025-07-16
A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Active not recruiting
NCT04237649 2025-05-18
KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
Novartis
Phase EARLY_PHASE1 Terminated
NCT06976931 2025-05-16
Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer
Jiangsu YaYao Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT06972602 2025-05-15
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1 Recruiting
NCT06951425 2025-05-13
An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase EARLY_PHASE1 Not yet recruiting
NCT06400485 2025-05-02
AMT-676 in Patients With Advanced Solid Tumors
Multitude Therapeutics Inc.
Phase EARLY_PHASE1 Recruiting
NCT06497010 2025-05-01
An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment
The Affiliated Hospital Of Guizhou Medical University
Phase EARLY_PHASE1 Recruiting
NCT05916248 2025-04-01
Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
Ruijin Hospital
Phase EARLY_PHASE1 Recruiting